|

Fluciclovine PET/CT in Multiple Myeloma Patients

RECRUITINGSponsored by Oslo University Hospital
Actively Recruiting
SponsorOslo University Hospital
Started2019-03-01
Est. completion2020-01-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT03966443

Summary

Comparison between image findings at aminoacid PET/CT and FDG PET/CT for myeloma patients

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Multiple myeloma patients suitable for ASCT treatment

Exclusion Criteria:

* Patients with contraindications to ASCT treatment

Conditions3

CancerMyeloma, MultiplePET-CT

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.